Monday November, 20th 2006
 


 

 


 

 

 Have you seen Brooke?

Check out our the NEW broadcast
www.QualityStocksLIVE.com

Check it out TODAY!!!

TUNE IN Monday!
11:00 AM EST

 QualityStocks.net on TradersNation.com with Brooke!
Each Day on TradersNation.com and QualityStocks.net.

About Traders Nation
Multiple segments make up the 'LIVE' hour-long program where listeners and viewers gather daily to hear the latest market news of the day and scheduled guests, from industry experts and CEO's. Traders also share investing, trading strategies and potential hot stock plays swirl throughout the call-in portion of the show.

For more information please visit www.tradersnation.com


Pilot Financial   Communications Network

In today’s ever changing financial environment Businesses recognize there is a new economy and culture taking root and shaping the business landscape.

Today companies must seek to promote uniqueness, values, and innovation…not simply out of want, but to survive within this new environment.

For more information please visit www.pilotfcn.com 



QuoteMedia (QMCI) is a leading software developer and syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages and financial services companies.

For more information please visit
www.quotemedia.com


 

Cashcow Magazine Online

Cashcow Magazine Online is an innovative online financial magazine dedicated to featuring new and emerging growth stocks to its affluent, web-savvy investor audience. CashcowMag.com has been around since 1997 and has become one of the industry's main go-to sources for up-to-date financial information.

For more information please visit www.CashcowMag.com


 

 Modavox, Inc., founded in 1999, is an online media company and the developer of the pioneering online VoiceAmerica™ Network. We are a leading software provider of enhanced communications, leveraging proprietary technology and unique competencies in the networked delivery of digital media.

For more information please visit www.Modavox.com


The Wall Street Savant is a leading online financial portal where investors can discover an array of financial tools to help build their investment IQ. The Wall Street Savant also provides comprehensive profiles on undiscovered and under-followed companies as well as well researched opinions on stocks for active traders. Comprehensive profiles are featured on The Wall Street Savant website and members are kept abreast on all new developments through regular email updates.

For more information please visit www.wallstreetsavant.com 

 

 

 

 

This unique website is recognized as one of the most selective domains for discovering future market leaders with market caps of less than $500 million. Owned and operated by Heritage First Capital & Equity Research Group (HFC), a smartsource funding agency, every company featured here offers compelling evidence for potential triple-digit returns. Dedicated to the individual investor, HFC publishes the award-winning quarterly newsletter Smallcap Brief.

For more information, please visit www.TCStocks.com

 

 


QualityStocks.net continues to monitor, rank, and deliver the best stocks from hundreds of Investment Newsletters. We are pleased to introduce The QualityStocks.net "Top-3" The QualityStocks.net Top-3 will Rank SmallCap newsletter performance from actual market performance that they produce. The QualityStocks.net Top-3, rewards firms with highest rank based on historical volume, and the frequency of newsletter appearance in The QualityStocks.net Top-Daily Mover Report and increases to in stock value, as measured daily:

  1.OTC Stock Exchange
  2.Beacon Equity Research
  3.Knobias Clip Report

About QualityStocks.net
QualityStocks.net is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report.

To sign up for "The QualityStocks Daily Newsletter" please visit Sign Up

 

The QualityStocks.net Daily Newsletter "One To Watch for Monday" was BioStem Inc. (BTEM) opening the day at $3.20 up 9% closing at $3.33 with 10,450 shares traded. (BTEM) was highlighted Friday by Quality Stocks.net.

BioStem Inc. announced today that reports published earlier this month support the increased diversity of the non-controversial umbilical cord blood stem cell. Researchers based at Newcastle University in the United Kingdom have grown an artificial mini-liver from umbilical cord blood stem cells. In a separate study scientists at the Clinical Cell Therapy Lab at the University of Minnesota report successfully differentiating cord blood cells into a type of lung cell called type II alveolar cells. The Newcastle University finding in late October is considered a critical breakthrough towards creating a completely artificial liver. Cord blood banking has been available since the early 1990s. Cryobanks International is the only National Marrow Donor Program (NMDP) accredited cord blood bank that offers a national collection model for donated cord blood units. According to the American Liver Foundation, liver disease is among the ten major causes of death in the United States. They report that one in every ten Americans -- 25 million -- are/or have been afflicted with a liver, billary or gallbladder disease. BioStem Inc. is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth.


Topping The QualityStocks.net Daily Newsletter for volume and percentage gained is Banyan Corporation (BANY) previously at $0.0011 up 418% to close at $0.0057 with 369,175,616 shares traded. (BANY) was highlighted today by OTC Stock Exchange and last month by BreakOutTrading.net

Banyan Corporation announced its initial results since it launched its newest medical device, the VT3000, to doctors nationwide. The VT3000 is a state-of-the art Electro-Diagnostic testing machine that pinpoints problems related to nerves, muscles, spinal cord or the brain. The VT3000 can be operated efficiently in doctors' offices, with "live viewing" by a certified technician, and rapid reading service from the Board Certified Physicians of VMS. The company reports initial sales of 50 machines, with sales of 50 additional machines expected within the next 90 days. Between the machine sales and ongoing testing revenues, these sales alone should generate yearly revenues of about $3,000,000- $4,000,000 from this initial marketing effort. This is in addition to the existing Premier business that is reporting strong growth for the quarter ending September 30, 2006. Banyan Corporation, through its subsidiaries, engages in the operation and franchising of chiropractic clinics in North America. It also provides diagnostic testing services. The company provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees.


Axis Technologies Group, Inc. (AXTG) previously at $1.25 up 34% at $1.68 with 2,972,882 shares traded. (AXTG) was highlighted this month by Beacon Equity Research, Boon Market, The Bull Report, The Capital Report, All Penny Stocks, Small Cap Voice, Twin Trader, The Subway, Knobias Clip Report, OTC Picks and today by BoonMarket.com, Bull Report and Knobias Clip Report.

Axis Technologies Group, Inc. announced today that Speedway Motors, a large performance auto components distributor has installed the Axis Dimming/Daylight Harvesting (DDH) Ballast system in their 42 -acre 520,000 square-foot corporate campuses located in Lincoln, Nebraska. After an initial installation of the Axis DDH ballasts, Speedway management monitored electricity savings in comparison to those of the previous T12 fluorescent system. The Axis DDH ballast was shown to reduce lighting energy costs by over 60%. Axis Technologies Group, Inc. also announced today that the Lincoln Electric System (an electric utility company) published a case study on energy savings following the installation of the Axis Technologies Dimming/Daylight Harvesting (DDH) ballasts in their headquarters in Lincoln, NE. An entire floor of the building was retrofitted with the Axis 4-lamp ballast system and a comparative case study followed. The Capital Report States "The word about AXTG is starting to spread as installations in several high profile areas such as DFW Airport, Harrah's Casino, and most recently Walgreens occur." Boon Market states "Since then, AXTG has put out great news every day after the close or before the open making for a great opportunity to sell into the gap up several days in a row." Axis Technology, Inc. designs, manufactures and markets a proprietary line of energy-saving and daylight harvesting electronic dimming ballasts for the commercial lighting industry. The company's target market is small to large commercial users of fluorescent lighting including office buildings, wholesale and retail buildings, hospitals, schools, and government buildings.


BlueFire Ethanol Fuels, Inc. (BFRE) previously at $3.10 up 29% at $4.00 with 133,389 shares traded. (BFRE) was highlighted this month by Knobias Clip Report, Wall Street Resources and today by Knobias Clip Report.

BlueFire Ethanol Fuels, Inc. announced today that BlueFire Ethanol was invited to the Northwest Energy Angels Investment Forum and presented its technology and deployment plans to business leaders in the Pacific Northwest, who provide investment capital, strategic advice and mentoring to early-stage companies or companies embarking on major expansion efforts to help them achieve market leadership. BlueFire Ethanol, Inc. was established to deploy the commercially ready, patented, and proven Arkenol Technology Process for the profitable conversion of cellulosic "Green" waste materials to ethanol, a viable alternative to gasoline. BlueFire's use of the Arkenol Process Technology positions it as the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash, rice and wheat straws, wood waste and other agricultural residues.


CoTherix Inc. (CTRX) previously at $11.20 up 19% at $13.42 with 2,520,131 shares traded. (CTRX) was highlighted this month by Knobias Clip report and today by Momentum Traders.
CoTherix Inc. announced today that Swiss biotech firm Actelion had agreed to buy CoTherix Inc. for $420 million in cash, gaining another treatment for an often-fatal lung condition and boosting shares of both companies. Under terms of the deal, shareholders of Brisbane, Calif.-based CoTherix will receive $13.50 per share for a 21 percent premium over the stock's Friday closing price of $11.20. CoTherix early last year introduced Ventavis, the only U.S.-approved inhaled treatment for pulmonary arterial hypertension (PAH), which Actelion estimates will generate 2007 sales of more than $100 million. CoTherix, Inc., a development stage company, engages in biopharmaceutical operations. It focuses on licensing, developing, and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases.


Universal Travel Group (UTVG) Closed at $1.11 with 24,518 shares traded. (UTVG) was highlighted today by Knobias and Small Cap Voice and (UTVG) was also highlighted by Wall Street Grapevine, Small Cap Voice, OTC Picks, OTC Financial Network earlier in the month.

Universal Travel Group announced today that the Company has formed a strategic partnership with TravelSky Technology Limited ("TravelSky"), an operating unit of China TravelSky Holding Company. TravelSky is the leading provider of information technology solutions for China's air travel and tourism industries. Under the terms of the agreement, TravelSky will provide a computerized service platform to YZL for management and processing of on/off line payment methods, online booking for hotels, and online airplane ticket booking services. Wall Street Grapevine States "UTVG ran high on news almost hitting $1.70; some nasty profit takers brought it down. However, that was actually a blessing in disguise as it has given you all a chance to buy shares that should more than double in price before the holidays." Universal Travel Group, through its wholly owned subsidiary, Yu Zhi Lu Aviation Service Company Ltd. ("YZL"), is engaged in travel services pertaining to domestic and international lines through Hong Kong, Macau, and Taiwan . The Company's core services include dynamic booking for air tickets, hotels, and restaurants, as well as tour routing for customers.

For more information please visit Universal Travel Group


Nascent Wine Co. (NCTW) closed at $1.00 with 400 shares traded. (NCTW) has been highlighted by Knobias Clip Report, Pilot Financial Communication and QualityStocks.net
Nascent Wine Co. Inc. announced late Friday that it has closed the previously announced transaction to acquire Palermo Foods, LLC. Palermo has been a major force in the pizzeria and casual dining business in Miami, Mexico, and Puerto Rico for nearly twenty years. Nascent Wine Co. operates in the beverage and food industry in Mexico. Nascent Wine Co. was founded in 2002 and is based in San Diego, California. For more information please visit Nascent Wine Nascent Wine Co. Inc. is charting a course to become a leader in the beverage and food industry in Mexico. The Company is the exclusive distributor of Miller Beer in Baja California, Mexico. The Company plans to continue acquiring small- to medium-sized beverage and food distributors in Mexico.


Sub Surface Waste Management of Delaware Inc. (SSWM) is Today's QualityStocks.net Daily Newsletter Spotlight Company opening at $0.04 closing at 0.0450 up 12% with 213,500 shares traded. (SSWM) was highlighted this month by SmallCapVoice.com and QualityStocks.net
Sub Surface Waste Management saw gains on no news to report. Sub Surface Waste Management of Delaware, Inc. engages in the design, installation, and operation of proprietary soil and groundwater remediation systems for clean up of toxic waste releases to soil and groundwater, and the bio-recycling of spent activated carbon filtration media. For more information please visit SSWM


Martin Nutraceuticals, Inc. (MNCL) closed the day at 0.10 with 169,139 shares traded. (MNCL) was highlighted today by OTC Stock Exchange (MNCL) was highlighted earlier in the month by OTC Stock Exchange Micro Cap Alliance, OTC Stock Review, OTC Picks, OTC Stock Exchange, HotOTC.com, InsideMove.com, Stock Egg, Cash Cow Mag Small Cap Voice and QualityStocks.net

Martin Nutraceuticals Inc. is a development stage company that develops and markets natural/complimentary medicine (nutraceuticals) for joint pain to the general consumer, increasing the activity of the immune system and obesity control. Martin Nutraceuticals has developed a family of innovative complimentary medicine to aid all types of difficulties to enhance a better lifestyle. In the United States alone, The nutraceutical market was worth approximately US$19 billion in 2004 according to the American Nutraceutical Association and this year the market is at over 68 billion. For more information please visit Martin Nutraceuticals


Press Release Source: Universal Travel Group

Universal Travel Group and TravelSky Technology Form Strategic Partnership
Monday November 20, 8:00 am ET

SHENZHEN, China and LOS ANGELES, Nov. 20 /PRNewswire-FirstCall/ -- Universal Travel Group ("Universal") (OTC: UTVG - News ), which, through its wholly owned subsidiary Yu Zhi Lu Aviation Service Company Ltd. ("YZL"), operates as a China-based aviation services company, announced today that the Company has formed a strategic partnership with TravelSky Technology Limited ("TravelSky"), an operating unit of China TravelSky Holding Company. TravelSky is the leading provider of information technology solutions for China's air travel and tourism industries. Under the terms of the agreement, TravelSky will provide a computerized service platform to YZL for management and processing of on/off line payment methods, online booking for hotels, and online airplane ticket booking services. The partnership allows the Company access to over 3,000 Chinese and foreign hotels in TravelSky's network for the benefit of Universal's customers.

Jiangping Jiang, CEO of Universal Travel Group, said, "The agreement with TravelSky is a boon to both the Company and our customers. The Company can immediately improve the bottom-line by consolidating the reservation and payment administration through a centralized IT infrastructure. The business and commercial traveler benefits from having over 3,000 hotels to choose from for their accommodations. I look forward to a long-term relationship with TravelSky. I anticipate this agreement will benefit our shareholders in the near- and long-term."

About Universal Travel Group

Universal Travel Group, through its wholly owned subsidiary, Yu Zhi Lu Aviation Service Company Ltd. ("YZL"), is engaged in travel services pertaining to domestic and international lines through Hong Kong, Macau, and Taiwan. The Company's core services include dynamic booking for air tickets, hotels, and restaurants, as well as tour routing for customers. For more information, visit http://www.chutg.com or http://www.otcfn.com/utvg .

The Private Securities Litigation Reform Act of 1995 provides a "Safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.

At the Company: Universal Travel Group Jacalyn Guo Investor Relations (310) 443-4151 [email protected] http://www.chutg.com Investor Relations: OTC Financial Network Peter Clark Investor Relations 781-444-6100, x629 [email protected] http://www.otcfn.com/utvg
Source: Universal Travel Group

.


Press Release Source: Cryobanks International, Inc.

Cryobanks International, Inc. Research Affiliates at the Center of Two Important Cord Blood Discoveries
Monday November 20, 8:15 am ET

ALTAMONTE SPRINGS, FL--(MARKET WIRE)--Nov 20, 2006 -- Reports published earlier this month support the increased diversity of the non-controversial umbilical cord blood stem cell. Researchers based at Newcastle University in the United Kingdom have grown an artificial mini-liver from umbilical cord blood stem cells. In a separate study scientists at the Clinical Cell Therapy Lab at the University of Minnesota report successfully differentiating cord blood cells into a type of lung cell called type II alveolar cells.

The Newcastle University finding in late October is considered a critical breakthrough towards creating a completely artificial liver. The importance of this finding for drug development is significant. Currently pharmaceutical companies use animal or human subjects to test treatments for liver diseases and ailments and in many cases the subjects suffer adverse reactions to the test drugs or therapies. Using cord blood stem cell derived mini-livers, pharmaceutical companies can test more applications and drugs without complications or adverse reactions of the testing subjects. The possibility of regenerating a new liver to replace one that has been damaged or destroyed by disease in now on the horizon.

According to the American Liver Foundation, liver disease is among the ten major causes of death in the United States. They report that one in every ten Americans -- 25 million -- are/or have been afflicted with a liver, billary or gallbladder disease. Chronic liver disease accounts for the death of 20,300 Americans each year and currently there are over 17,000 people awaiting a liver transplant.

Another significant finding came from researchers at the Clinical Cell Therapy Lab at the University of Minnesota, Fairview. Working with BioE Inc., St. Paul, MN, they reported successfully differentiating cord blood cells into a type of lung cell called type II alveolar cells. The research team cultured BioE's unique Multi-Line Progenitor Cell™ (MLPC™) differentiating it into the lung cells. The ability to grow this cell will greatly aid in the study and development of more effective treatments for various lung diseases such as cystic fibrosis.

More than 35 million Americans have an ongoing lung disease like asthma or chronic obstructive pulmonary disease (COPD). Combining all types of lung disease together it is the number three killer in the United States causing 1 in 7 deaths each year.

"These two discoveries are important additions to the growing list of uses and applications of non-controversial cord blood stem cells, a resource that is virtually limitless. This is further scientific proof that these cells can differentiate to become other than simply blood cells and opens an entirely new chapter in the umbilical cord blood stem cell story," said Cryobanks International President and CEO Dwight Brunoehler.

Newcastle University and University of Minnesota are leaders in the cord blood stem cell research and development field working on a number of studies and projects. In another project headed by BioE Inc., Cryobanks International, Inc., Newcastle and the University of Minnesota are research partners working to develop a new cord blood processing methodology.

"We are honored to be working with these fine institutions and BioE in a separate project that we believe will also have a significant impact on the developing cord blood banking field," continued Mr. Brunoehler.

About Cryobanks:

Cryobanks International, Inc. is a corporation located in Altamonte Springs, Fl., which is to be acquired by BioStem, Inc. (OTC BB: BTEM.OB - News ). The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood (CB) are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplants (BMTs). There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International, Inc. is well poised to help meet that need, equipped with an inventory of over 9,000 cord blood units. For more information about Cryobanks International, Inc. call 1-800-869-8608 or visit the website at www.cryo-intl.com .

Safe Harbor Statement

This press release contains "forward-looking statements" by BioStem, Inc. These statements relate to future events or financial performance and transactions, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements, to be materially different from those contemplated by the forward-looking statements. There can be no assurance that the acquisition described herein will successfully close. We undertake no ongoing obligation, other than that imposed by law, to update these statements. Factors that could affect results, levels of activity, performance or achievements and cause them to materially differ from those contained in the forward-looking statements include the failure to complete the acquisition of Cryobanks, and other factors that can be found in BioStem's filings with the Securities and Exchange Commission, which can be found at www.sec.gov .
Contact: Contact: Robert Gravely Cryobanks International, Inc. Phone: 407-834-8333 Fax: 407-834-3533 Email Contact http://www.cryo-intl.com Source: Cryobanks International, Inc.


       



 

Copyright 2006 QualityStocks.net 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ. 85251 480-308-9035

Click Here for Disclaimer